Skip to main content
TLSI logo

TLSI · TriSalus Life Sciences, Inc. · Metrics

Track TLSI — free
$3.59 -0.07 (-1.91%) At close · Oct 23
Market Cap
$221.05M
Shares
61.57M
Volume · Oct 23 78.4K Avg daily vol (3M) 261.75K

TLSI metrics

84 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.59
Market cap
$221.05M

Price action

20 metrics
Price change (1W)
-1.1%
Price change (30D)
-17.3%
Price change (3M)
-14.9%
Price change (6M)
-22.6%
Price change (YTD)
-48.6%
Price change (1Y)
-30.0%
Trailing year
Price change (5Y)
-63.7%
52-week high
$7.50
52-week low
$2.52
Change from 52-week high
-52.1%
Change from 52-week low
+42.5%
Annualized volatility
79.1%
Annualized volatility (3M)
55.3%
Beta
1.1
RSI (14D)
29.6
Price vs SMA 50
-21.7%
Price vs SMA 200
-19.4%
Avg volume (3M)
261,753
Relative volume
0.3
Average dollar volume
$1.25M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
61.57M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.6×
reciprocal yield 21.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
4.9×
reciprocal yield 20.4%
P / book
33.7
reciprocal yield 3.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-12.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-10
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
85.8%
Operating margin
-67.7%
Trailing 12 months
Net margin
-62.6%
Gross profit (TTM)
$38.67M
Operating profit (TTM)
−$30.51M
Net income (TTM)
−$28.21M
Trailing 12 months
Diluted EPS (TTM)
$-1.31
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.92
Gross profit per diluted share (TTM)
$0.79
Operating profit per diluted share (TTM)
$-0.61
EBITDA per diluted share (TTM)
$-0.60
Net income per diluted share (TTM)
$-0.59
Operating cash flow per diluted share (TTM)
$-0.44
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.30
Stock compensation per diluted share (TTM)
$0.22
Book value per share
$-0.68

Growth

11 metrics
Revenue growth YoY
+1.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$45.08M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+77.2%
Year over year · more shares
Revenue CAGR (3Y)
+53.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-430.7%
Return on assets
-45.2%
Debt / equity
5.0
Current ratio
5.3
EBITDA (TTM)
−$29.95M
Free cash flow (TTM)
—
Quick ratio
5.0
Interest coverage
-5.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$13.22M
Latest balance sheet
Cash & equivalents
$46.29M
Total assets
$62.45M
Total debt
$33.06M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$22.80M
Capital expenditures (TTM)
$480,000
R&D (TTM)
$14.63M
SG&A (TTM)
—
Stock compensation (TTM)
$10.71M
R&D / revenue
32.4%
Stock compensation / revenue
23.8%

Ownership (13F)

9 metrics
13F filers
82
13F filer change QoQ
-8
Institutional ownership
37.0%
Conviction holders (share of 13F filers)
1.3%
Crowding (high-turnover and private-fund holders)
18.5%
Private-fund adviser ownership
18.5%
Active holders' share change QoQ
-12.7%
Holder tenure
4.5
Price vs estimated holder cost
-4.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.6%

Short interest

3 metrics
Short interest
5.4%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
51 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4,113
Insider-sentiment score
47 / 100

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1826667 CUSIP 89680M101 13F (30d) 12 filings 12 filers Visit website Investor relations